Efficacy of Saffron ( Crocus sativus L.) and Its Constituents on Breast Cancer, a Systematic Review of Preclinical Studies and Potential Therapeutic Mechanisms
Integrative Cancer Therapies · 2025
DOI: 10.1177/15347354251361450 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Integrative Cancer Therapies, 2025. Verfasst von Fatemeh Sadat Hasheminasab und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. Hauptthemen laut MEDLINE: Crocus, Breast Neoplasms, Plant Extracts, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Breast cancer is the most common cancer and the main cause of death because of malignant tumors in women, worldwide. The impact of Crocus sativus on several cancers has been discussed. Recent studies provide evidence regarding the anticancer properties of C. sativus and its bioactive constituents against breast cancer. This study aims to systematically review the efficacy of this botanical drug and its constituents on breast cancer, and their mechanism of action for the first time. Due to the lack of human studies in this field, the present research focused on preclinical studies.
Methods
In this systematic review, scientific databases, including PubMed, Web of Sciences, Google Scholar, Scopus, and Scientific Information Database were explored profoundly. Preclinical studies published until the end of 2024 that had investigated the therapeutic properties of C. sativus , or its bioactive constituents including crocin, crocetin, safranal, or picrocrocin against breast cancer were selected.
Results
Forty-four studies examining the effect of C. sativus or its bioactive constituents against breast cancer were obtained. Preclinical in vitro and in vivo studies have demonstrated the potential and targeted anticancer properties of the metabolites found in saffron ( C. sativus ). These metabolites, such as crocin, crocetin, and safranal, exhibit their anticancer effects through various mechanisms, including induction of apoptosis, modulation of the cell cycle, and other pathways.
Conclusions
C. sativus and its constituents exerts their anticancer activity with different mechanisms. A considerable number of the included studies highlight induction of apoptosis and modulation of the cell cycle. The findings of our study suggest that certain compounds, particularly crocin and crocetin, have significant anticancer properties. In particular, crocin provided the highest level of evidence of efficacy in preclinical research, indicating its potential for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
- Department of Genetic, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
- Gastroenterology and Hepatology Research Center, Kerman University of Medical Sciences, Kerman, Iran.
ORCID-Profile: Fatemeh Sadat Hasheminasab, Maryam Azimi
Zitieren
APA
Hasheminasab, F. S., & Azimi, M. (2025). Efficacy of Saffron ( Crocus sativus L.) and Its Constituents on Breast Cancer, a Systematic Review of Preclinical Studies and Potential Therapeutic Mechanisms. Integrative Cancer Therapies. https://doi.org/10.1177/15347354251361450
Vancouver
Hasheminasab FS, Azimi M. Efficacy of Saffron ( Crocus sativus L.) and Its Constituents on Breast Cancer, a Systematic Review of Preclinical Studies and Potential Therapeutic Mechanisms. Integrative Cancer Therapies. 2025. doi:10.1177/15347354251361450
BibTeX
@article{Hasheminasab2025,
author = {Hasheminasab, Fatemeh Sadat and Azimi, Maryam},
title = {Efficacy of Saffron ( Crocus sativus L.) and Its Constituents on Breast Cancer, a Systematic Review of Preclinical Studies and Potential Therapeutic Mechanisms},
journal = {Integrative Cancer Therapies},
year = {2025},
doi = {10.1177/15347354251361450}
}
EUVIMED